tiprankstipranks
Advertisement
Advertisement

Silex Systems Boosts Cash Reserves as Revenue Doubles but Loss Persists

Story Highlights
  • Silex Systems significantly strengthened its balance sheet, more than doubling revenue while slightly narrowing its net loss for the half-year.
  • The company is deepening investment in SILEX laser enrichment across nuclear fuel, quantum computing materials and medical isotopes to bolster its strategic market position.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Silex Systems Boosts Cash Reserves as Revenue Doubles but Loss Persists

Claim 55% Off TipRanks

Silex Systems Limited ( (AU:SLX) ) has shared an announcement.

Silex Systems reported a sharp improvement in liquidity for the half-year ended 31 December 2025, with cash, term deposits and dual currency term deposits rising 150.4% to about $201.7 million from June 2025. Revenue from ordinary activities more than doubled year-on-year to $14.2 million, while the net loss attributable to members narrowed slightly to $17.9 million, and the company did not declare a dividend.

The results underscore Silex’s continued investment in commercialising its SILEX laser enrichment technology across uranium, quantum computing materials and medical isotopes. With its uranium enrichment venture Global Laser Enrichment jointly controlled with Cameco Corporation, Silex is positioning itself as a key contributor to secure nuclear fuel supply and emerging high-tech markets, despite remaining loss-making during the period.

The most recent analyst rating on (AU:SLX) stock is a Hold with a A$7.00 price target. To see the full list of analyst forecasts on Silex Systems Limited stock, see the AU:SLX Stock Forecast page.

More about Silex Systems Limited

Silex Systems Limited is a technology company focused on commercialising its proprietary SILEX laser enrichment technology for global nuclear fuel markets. The company’s primary activities include uranium enrichment for nuclear power, development of highly enriched silicon-28 for quantum computing chips, and potential production of medical isotopes such as ytterbium-176 for advanced cancer treatments.

Average Trading Volume: 1,675,314

Technical Sentiment Signal: Buy

Current Market Cap: A$1.93B

For detailed information about SLX stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1